Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Tianjin Huanhu Hospital
Brain Inflammation Collaborative
Tongji Hospital
Tongji Hospital
University of Pittsburgh
Mayo Clinic
Centre Hospitalier Régional d'Orléans